270) hedding light on their involvement in the disease processes. |
271) y the role of IsoLGs in a wide variety of disease processes. |
272) Osteosarcoma is a challenging bone disease which is commonly associated with |
273) exaggerated immune response (inflammatory disease), which may prove detrimental to t |
274) f mitochondrial import machinery in heart disease, which deserves considerable atten |
275) s follows: (1) "general manifestations of disease," which included behavioral change |
276) e-related neurodegeneration and Alzheimer Disease (AD), and assess the potential of |
277) d cogniitve impairment (MCI), Alzheimer's disease (AD), and Parkinson's disease (PD) |
278) Alzheimer's disease (AD), the most common form of deme |
279) eased risk of non-diabetic chronic kidney disease (CKD) and in particular of HIV ass |
280) g KLM formation in various chronic kidney disease (CKD) models. |
281) BACKGROUNDAssessment of chronic kidney disease (CKD) risk after acute kidney inju |
282) ve and safe in patients with a stable low disease activity, although more (high-qual |
283) serological measures of EBV reactivation, disease activity, and interferon (IFN)-ass |
284) led “dose tapering”), once stable low disease activity, or even remission, is re |
285) ill continue to bear an unacceptably high disease burden from climate change. |
286) served in mice may not explain the higher disease burden of COVID-19 among men. |
287) of EEEV could change resulting in higher disease burden or spread into previously u |
288) Key Points • Disease flare during pregnancy in patients |
289) Disease flare occurred in 25-80% of patien |
290) Most studies reported disease flare during pregnancy, and few re |
291) y peptide in conditions other than celiac disease, including collagen-induced arthri |
292) ing available to many people with chronic disease, including multiple sclerosis (MS) |
293) ge-varying relative risk profiles in nine diseases, including hypertension, skin can |
294) eted sequencing of variants and monogenic disease risks and returned to participants |
295) ntly associated with cardio-metabolic and disease risks in adults. |
296) ges to reduce obesity and noncommunicable disease risks. |
297) g focus on the role of diet in health and disease, we have only a limited understand |
298) To assess the heterogeneity of this disease, we recently conducted a clinical |
299) correlates of maternal mental health and disease, we will be better equipped to pre |
300) Canavan disease (CD) is a progressive, fatal neuro |
301) s been suggested to be involved in celiac disease (CD) pathogenesis by mediating int |
302) Chronic obstructive pulmonary disease (COPD) is the third leading cause |
|